Krishnan Krish S

President and CEO, Director, 10% OwnerKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.6M
Net Open-Market Flow
-$6.6M
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)483$257.31$124K1.5M
Mar 4, 2026Sell(S)470$258.38$121K1.5M
Mar 4, 2026Sell(S)1K$259.87$358K1.5M
Mar 4, 2026Sell(S)3K$260.49$815K1.5M
Mar 4, 2026Sell(S)920$266.56$245K1.5M
Mar 4, 2026Sell(S)2K$262.44$625K1.5M
Mar 4, 2026Sell(S)2K$263.70$539K1.5M
Mar 4, 2026Sell(S)9K$264.85$2.3M1.5M
Mar 4, 2026Sell(S)2K$265.59$648K1.5M
Mar 4, 2026Sell(S)3K$261.41$774K1.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001298709-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: